Delhi High Court: Providing Email Services Does Not Make Google a Public Functionary || Patna HC: Lying on a Woman Without Any Act Toward Penetration Rules Out Attempted Rape || Delhi High Court: Litigants Cannot Claim a Bench Change as a Right After Roster Changes || Calcutta High Court: Peaceful Protest is a Democratic Right and Cannot Be Treated as an Offence || Delhi High Court: Trial Courts Must Verify an Accused’s Address Before Declaring Absconding || Gujarat High Court: Judicial Officer Cannot Seek HC Judge’s Transfer over Housing Grievance || Delhi High Court Orders 125 Websites Using Jio Trademark for Lottery and Gaming to Be Suspended || MP High Court Strikes Down 27% OBC Quota, Restores Reservation to 14% || Supreme Court: Hindu Widow’s Limited Estate Became Absolute under Succession Act || Supreme Court: Prima Facie Arbitration Agreement Requires Referral to Arbitration

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :